|
End-of-day quote
Shenzhen S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 29.12 CNY | +1.22% |
|
-5.64% | -13.20% |
| 04/09 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 04/09 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 1.31TCr 195.9Cr 175.76Cr 162.5Cr 147.17Cr 274.96Cr 19TCr 278.28Cr 1.94TCr 773.87Cr 9.76TCr 735.14Cr 719.63Cr 31TCr | P/E 2026 * |
25.1x | P/E 2027 * | -127x |
|---|---|---|---|---|---|
| Enterprise Value | 1.31TCr 195.9Cr 175.76Cr 162.5Cr 147.17Cr 274.96Cr 19TCr 278.28Cr 1.94TCr 773.87Cr 9.76TCr 735.14Cr 719.63Cr 31TCr | EV / Sales 2026 * |
12.1x | EV / Sales 2027 * | 10.4x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.22% | ||
| 1 week | -5.64% | ||
| Current month | -12.47% | ||
| 1 month | -10.40% | ||
| 3 months | -15.50% | ||
| 6 months | -24.77% | ||
| Current year | -13.20% |
| 1 week | 28.41 |  | 30.55 |
| 1 month | 28.41 | | 33.8 |
| Current year | 28.41 | | 45.88 |
| 1 year | 28.41 | | 56.88 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
Liang Wen Huang
CHM | Chairman | 50 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/01/26 | Buy | Director | 4,200 | 0.0010% | ||
| 24/11/25 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.22% | -5.64% | -45.44% | +3.01% | 195.9Cr | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,14800Cr | |
| +0.86% | +5.14% | +45.00% | +86.15% | 65TCr | |
| -0.14% | +0.42% | +25.69% | +105.85% | 51TCr | |
| +0.38% | +2.35% | +54.11% | +66.31% | 38TCr | |
| -0.63% | -5.97% | +61.93% | +37.06% | 35TCr | |
| +2.07% | +2.53% | +34.15% | +56.14% | 29TCr | |
| +0.84% | -0.62% | +2.71% | +26.25% | 26TCr | |
| +0.87% | +3.08% | +54.69% | +72.74% | 24TCr | |
| +0.08% | +3.67% | +35.05% | +107.78% | 20TCr | |
| Average | +0.61% | +1.11% | +32.50% | +69.12% | 40.39TCr | |
| Weighted average by Cap. | +0.51% | +1.50% | +44.85% | +89.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108Cr 16Cr 15Cr 13Cr 12Cr 23Cr 1.54TCr 23Cr 160.66Cr 64Cr 807.3Cr 61Cr 60Cr 2.56TCr | 125.8Cr 19Cr 17Cr 16Cr 14Cr 26Cr 1.8TCr 27Cr 187.13Cr 75Cr 940.36Cr 71Cr 69Cr 2.99TCr |
| Net income | 53Cr 7.89Cr 7.08Cr 6.54Cr 5.93Cr 11Cr 751.39Cr 11Cr 78Cr 31Cr 393.19Cr 30Cr 29Cr 1.25TCr | -10Cr -1.53Cr -1.37Cr -1.27Cr -1.15Cr -2.15Cr -145.71Cr -2.17Cr -15Cr -6.04Cr -76Cr -5.74Cr -5.62Cr -242.05Cr |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | CN¥29.12 | +1.22% | 27,11,481 |
| 27/26/27 | CN¥28.77 | -4.86% | 35,50,500 |
| 26/26/26 | CN¥30.24 | -0.10% | 27,34,338 |
| 23/26/23 | CN¥30.27 | +2.47% | 44,24,788 |
| 22/26/22 | CN¥29.54 | -4.28% | 36,74,999 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
